The short answer: nobody has studied it, because nobody has studied injecting GHK-Cu at all.
There is no published human trial of injected GHK-Cu. Every human study of it is a cream or a patch. So when your stomach is on fire for eight hours after a shot, there's no paper that measured how often that happens or why.
What does exist is good chemistry on copper, decent research on why injections hurt in general, and a lot of people comparing notes on Reddit. Put together, they point in a pretty clear direction.
Status as of October 21, 2026: GHK-Cu is not FDA-approved for any use. FDA is reviewing GHK-Cu for compounding, but only for non-injectable routes after the injectable nomination was withdrawn. An FDA advisory committee meeting covering GHK-Cu is set for before the end of February 2027. Nothing below is medical advice or an injection guide.
Where I get mine: the vendors I use, and how I vetted them.
Has anyone studied GHK-Cu injections in humans?
No. A PubMed search turns up no human injection study, and the only registered human trials are a topical gel and a skin patch (ClinicalTrials.gov). An independent review published in August called GHK-Cu "a promising but unproven therapeutic cargo rather than a clinically validated regenerative drug" (Pharmaceutics, 2026).
The injection research that exists is in rats and dogs. The cosmetic research is in women using face creams. Most of the reviews you'll find were written by Loren Pickart, who discovered the peptide in 1973 (PubMed). That doesn't make them wrong. It does mean the literature runs through one lab.
Why does GHK-Cu burn?
The leading suspect is copper that isn't attached to the peptide.

GHK grabs copper very tightly, tighter than albumin, the main copper carrier in your blood (BioMed Res Int, 2015). Bound copper is calm. Free copper isn't. In a skin-cell study, plain copper salts set off irritation markers while GHK-Cu didn't change them at all (Sci Rep, 2016). Copper ions can also switch on TRPA1, one of the pain-sensing channels on nerves (J Appl Physiol, 2010).
The 2026 review calls free copper "the single most consequential attribute" of these products, and points out that most don't report it (Pharmaceutics, 2026). Grey-market vials certainly don't. Your COA tells you purity and maybe copper content. It doesn't tell you how much copper is floating loose.
So the honest version: free copper is a plausible cause with real chemistry behind it. Nobody has tested it in a GHK-Cu injection.
Two other explanations come up a lot:
"It's a histamine reaction." There's no data for that. The one study on copper and mast cells found copper reduced histamine release in rat cells (PubMed, 1989).
"It's the bacteriostatic water." Unlikely. The benzyl alcohol in it actually works as a mild local anesthetic and has been used to make lidocaine shots hurt less.
What does injection-pain research say in general?
A 2019 review of what makes under-the-skin injections hurt pulled together the trials (Adv Ther, 2019, funded by Sandoz). None of it tested GHK-Cu, but some of it lines up with what users report:
Factor | What the research found | Lines up with GHK-Cu reports? |
|---|---|---|
Cold solution | Refrigerated injections hurt more; the review says to let them reach room temperature first | Yes. "Let it warm up" is one of the most repeated fixes |
Concentration | Solutions far from the body's own concentration hurt more | Probably. "More water, less burn" is the most common fix |
Volume | Small volumes (under about half a mL) barely change pain | Neutral |
Injection speed | Made no difference in saline and lidocaine trials | No. Many users swear slow helps. Those trials didn't use an irritant |
Site | Thigh hurt more than abdomen in saline trials | No. GHK-Cu users mostly say the stomach burns worst |
Where the research and the reports disagree, nobody knows which is right for GHK-Cu.
How long does the GHK-Cu burn last?
According to users, usually hours. These are self-reports, not data.
It often doesn't start right away. People describe it hitting 10 minutes to an hour after the shot (r/peptides4dummies_).
Most say it lasts hours. Reports range from about 8 hours to a full day (r/Biohacking), and a few say 48 hours or longer.
Lumps can outlast the burn. A lump for about a week is commonly reported (r/BiohackingU), with some lasting much longer.
It's personal. Couples report one partner burning and the other feeling nothing from the same vial (r/BiohackingU).
What do people do about the burn?
This is what users report, from the most-upvoted thread on it, "GHK-CU burns like a MF" (r/Peptides, Oct 10, 2026), and similar threads. It's not advice, none of it has been tested, and plenty of people say they tried all of it and still quit.
More water when mixing. The most common fix by far. It's also the one with the most plausible logic: whatever is irritating, there's less of it per drop.
Letting the solution warm to room temperature. The only fix with general research support.
A different site. Many move away from the stomach. Responses are individual.
Injecting slowly. Commonly reported, untested.
A longer needle. Some say going deeper stopped the sting. Untested.
Splitting one shot across two spots. Untested.
One user who tried everything put it plainly: the painkillers and antihistamines they were taking every night "were probably doing more damage to my body than was worth it."
When is it more than a burn?
Most of what people describe fades within a day. Some things shouldn't be waited out:
A spot that gets hotter, redder and more painful each day instead of fading. As one user said, "non-sterile vials cause real infections" (r/Peptides).
Redness that spreads.
Fever or chills after a shot.
Lumps that are still there weeks later.
Any swelling of the lips or face, or trouble breathing. That's an emergency.
There's also the copper itself. The 2026 review flags copper building up in the liver as the main long-term concern with repeated injections, and says dietary copper limits can't be applied to injections (Pharmaceutics, 2026). NPR reported a clinician who saw raised liver enzymes and copper levels in patients who'd been injecting it, though it wasn't clear what caused them (NPR, Sept 7, 2026). If you have a copper-handling condition like Wilson's disease, this matters more.
Does the blue color mean it's good?
No. The blue comes from copper bound to the peptide, which is normal. But free copper is blue too. A blue vial tells you there's copper in it. It doesn't tell you the copper is bound or the peptide is intact. Why a clear or blue vial can still be degraded is covered in how long peptides last once mixed.
Where GHK-Cu stands with the FDA
Not approved for any use.
Non-injectable GHK-Cu is in Category 1, under evaluation for compounding. The injectable nomination was withdrawn (FDA, May 14, 2026).
Injectable GHK-Cu is on FDA's list of substances with possible safety risks, which cites immune reactions, impurities and limited human data (FDA).
An advisory committee will review GHK-Cu, LL-37, Dihexa, Melanotan II and PEG-MGF before the end of February 2027 (FDA). FDA hasn't said whether that covers injection.
Every one of those is on the compounding status tracker, updated when the paperwork moves.
Next step: see the vendors I use and how they score on testing, reviews and support. Code BHN40 takes 40% off.
If you've dealt with the burn, reply and tell me what you noticed: when it started, how long it lasted, and whether anything changed it. Nobody has studied this. You're the dataset.
